Page 284 - Read Online

Mohamedi et al. J Cancer Metastasis Treat 2019;5:37 I http://dx.doi.org/10.20517/2394-4722.2018.81 Page 15 of 15

30. Xu Z, Chen H, Liu D, Huo J. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
Medicine (Baltimore) 2015;94:e663.
31. Cheng YY, Jin H, Liu X, Siu JM, Wong YP, et al. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J
Cancer 2008;99:2083-7.
32. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, et al. Promoter hypermethylation of fibulin 1 gene is associated with tumor
progression in hepatocellular carcinoma. Mol Carcinog 2011;50:571-9.
33. Xiao W, Wang J, Li H, Xia D, Yu G, et al. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence. BMC
Cancer 2014;14:677.
34. Fontanil T, Mohamedi Y, Cal S, Obaya AJ. Assessing the influence of a protease in cell migration using the barrier-migration assay.
Methods Mol Biol 2018;1731:133-43.
35. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. In vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev 2003;17:1253-70.
36. Gyorffy B, Benke Z, Lanczky A, Balazs B, Szallasi Z, et al. RecurrenceOnline: an online analysis tool to determine breast cancer
recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat 2012;132:1025-34.
37. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation,
motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem
2002;277:27367-77.
38. Mohamedi Y, Fontanil T, Solares L, Garcia-Suarez O, Garcia-Piqueras J, et al. Fibulin-5 downregulates Ki-67 and inhibits proliferation
and invasion of breast cancer cells. Int J Oncol 2016;48:1447-56.
39. Alford AI, Kozloff KM, Hankenson KD. Extracellular matrix networks in bone remodeling. Int J Biochem Cell Biol 2015;65:20-31.
40. Kern CB, Twal WO, Mjaatvedt CH, Fairey SE, Toole BP, et al. Proteolytic cleavage of versican during cardiac cushion morphogenesis.
Dev Dyn 2006;235:2238-47.
41. Martino-Echarri E, Fernandez-Rodriguez R, Rodriguez-Baena FJ, Barrientos-Duran A, Torres-Collado AX, et al. Contribution of
ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on
nidogen-1 and nidogen-2. Int J Cancer 2013;133:2315-24.
42. Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, et al. Dysregulated expression of adamalysin-thrombospondin genes in human
breast carcinoma. Clin Cancer Res 2004;10:2429-40.
43. Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary
cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol 2009;174:1650-62.
44. Esselens C, Malapeira J, Colome N, Casal C, Rodriguez-Manzaneque JC, et al. The cleavage of semaphorin 3C induced by ADAMTS1
promotes cell migration. J Biol Chem 2010;285:2463-73.
45. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer
Cell 2003;3:537-49.
46. Lu X, Wang Q, Hu G, van Poznak C, Fleisher M, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic
signaling cascade for bone metastasis. Genes Dev 2009;23:1882-94.
47. Fontanil T, Rua S, Llamazares M, Moncada-Pazos A, Quiros PM, et al. Interaction between the ADAMTS-12 metalloprotease and
fibulin-2 induces tumor-suppressive effects in breast cancer cells. Oncotarget 2014;5:1253-64.
48. Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, et al. Immunological and pathobiological roles of fibulin-1 in breast cancer.
Oncogene 2004;23:2153-60.
49. Feng L, Yao C, Li P, Feng Y, Wang F, et al. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer. Tumour
Biol 2016;37:9399-410.
50. Fontanil T, Alvarez-Teijeiro S, Villaronga MA, Mohamedi Y, Solares L, et al. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and
ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells. Oncotarget 2017;8:13716-29.